down arrow

ProKidney Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG7S53R1049
USD
2.57
0.32 (14.22%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

2.412.59

52 Week

0.467.13
Valuation
Technical
Day's Volume

CASH

1.34 M

Shareholding (Mar 2025)

FII

2.72%

Held by 32 FIIs

DII

80.94%

Held by 22 DIIs

Promoter

0.00%

How big is ProKidney Corp.?

22-Jun-2025

As of Jun 18, ProKidney Corp. has a market capitalization of 251.11 million, with net sales of 0.31 million and a net profit of -165.95 million over the latest four quarters. Shareholder's funds are at -994.95 million, and total assets are 442.14 million as of Dec 24.

As of Jun 18, ProKidney Corp. has a market capitalization of 251.11 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 0.31 million, while the sum of Net Profit for the same period is -165.95 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at -994.95 million and Total Assets at 442.14 million.

Read More

What does ProKidney Corp. do?

22-Jun-2025

ProKidney Corp. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $38 million as of March 2025, with a market cap of $251.11 million. Key metrics include a debt-to-equity ratio of 0.33 and a return on equity of 16.09%.

Overview:<BR>ProKidney Corp. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025)<BR>Most recent Net Profit: -38 Million (Quarterly Results - Mar 2025)<BR>Market-cap: USD 251.11 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making)<BR>Industry P/E: NA<BR>Dividend Yield: 0.00%<BR>Debt Equity: 0.33<BR>Return on Equity: 16.09%<BR>Price to Book: -0.25<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is ProKidney Corp. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, ProKidney Corp. shows a mildly bullish trend with a year-to-date return of 60.36%, outperforming the S&P 500's 12.22%, but underperforming over the past year with a return of 13.39% compared to the S&P 500's 17.14%.

As of 12 September 2025, the technical trend for ProKidney Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a mildly bullish daily moving average and a bullish indication from the Bollinger Bands on both weekly and monthly time frames. The KST is bullish on both weekly and monthly charts, while the MACD shows a mixed signal with a mildly bearish weekly and mildly bullish monthly reading. The Dow Theory indicates a mildly bullish monthly trend, but the OBV is mildly bearish on the monthly. <BR><BR>In terms of performance, ProKidney has returned 60.36% year-to-date, significantly outperforming the S&P 500's 12.22% over the same period, although it has underperformed the index over the past year with a return of 13.39% compared to the S&P 500's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 636 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.29

stock-summary
Return on Equity

15.87%

stock-summary
Price to Book

-0.63

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-37 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.9%
0%
8.9%
6 Months
229.83%
0%
229.83%
1 Year
32.47%
0%
32.47%
2 Years
52.52%
0%
52.52%
3 Years
-75.07%
0%
-75.07%
4 Years
-74.04%
0%
-74.04%
5 Years
0%
0%
0.0%

ProKidney Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is ProKidney Corp. technically bullish or bearish?

As of 12 September 2025, the technical trend for ProKidney Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a mildly bullish daily moving average and a bullish indication from the Bollinger Bands on both weekly and monthly time frames. The KST is bullish on both weekly and monthly charts, while the MACD shows a mixed signal with a mildly bearish weekly and mildly bullish monthly reading. The Dow Theory indicates a mildly bullish monthly trend, but the OBV is mildly bearish on the monthly. In terms of performance, ProKidney has returned 60.36% year-to-date, significantly outperforming the S&P 500's 12.22% over the same period, although it has underperformed the index over the past year with a return of 13.39% compared to the S&P 500's 17.14%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-86.65%
EBIT Growth (5y)
-160.67%
EBIT to Interest (avg)
-82.48
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.33
Sales to Capital Employed (avg)
-0.00
Tax Ratio
0.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
47.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.29
EV to EBIT
0.23
EV to EBITDA
0.24
EV to Capital Employed
0.03
EV to Sales
-41.50
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.55%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 29 Schemes (16.35%)

Foreign Institutions

Held by 32 Foreign Institutions (2.72%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 3.90% vs -10.63% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-38.20",
          "val2": "-42.10",
          "chgp": "9.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-37.00",
          "val2": "-38.50",
          "chgp": "3.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-179,678.70%",
          "val2": "0.00%",
          "chgp": "-17,967.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -20.61% vs 8.58% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-174.00",
          "val2": "-148.40",
          "chgp": "-17.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-163.30",
          "val2": "-135.40",
          "chgp": "-20.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,346,736.80%",
          "val2": "0.00%",
          "chgp": "-2,34,673.68%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.20
0.00
Operating Profit (PBDIT) excl Other Income
-38.20
-42.10
9.26%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-37.00
-38.50
3.90%
Operating Profit Margin (Excl OI)
-179,678.70%
0.00%
-17,967.87%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 3.90% vs -10.63% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.10
0.00
Operating Profit (PBDIT) excl Other Income
-174.00
-148.40
-17.25%
Interest
0.00
0.00
Exceptional Items
-5.30
0.00
Consolidate Net Profit
-163.30
-135.40
-20.61%
Operating Profit Margin (Excl OI)
-2,346,736.80%
0.00%
-2,34,673.68%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -20.61% vs 8.58% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About ProKidney Corp. stock-summary
stock-summary
ProKidney Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."